MEDICINAL ORGANIC CHEMISTRY GROUP

Proteolysis-targeting chimeric technology for the development of mutant p53-based anticancer drugs

Source of Funding: Fundação para a Ciência e a Tecnologia (FCT)

Period: 2025-2027

PI: Maria M. M. Santos

Link: https://medorgchemlab.wixsite.com/protac4oncop53

​

From CHemical design to MEchanisms: an innovative pipeline for optimization and characterization of anti-LEISHmania new scaffolds

Source of Funding: Fundação para a Ciência e a Tecnologia (FCT)

Period: 2026-2029

PI: Sofia Cortes

Project Reference: 2025.18452.PTDC